ABT-450 combo achieves high SVR12 in hepatitis C

FROM THE LIVER MEETING 2014A combined formula of ABT-450 with ritonavir, ombitasvir, and dasabuvir, given with ribavirin, yielded high rates of sustained viral response at 12 weeks among...

Field of Interest: Gastroentero...
Type: News Item

VIDEO: Hepatitis C burden could wallop Medicare

BOSTON – The graying of America will add at least 1 million more patients with chronic hepatitis C virus infection into the Medicare system between 2010 and 2024. “If all of these patients were...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness